SCHEMBL19014232

SCHEMBL19014232

COC(=O)c1cc2c(C)ccc(Cl)c2n1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NR1H2 P55055 1/20 0.39
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 3/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
AURKA O14965 1/20 0.35
CDK2 P24941 1/20 0.35
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PKM P14618 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
MDM2 Q00987 1/20 0.33
PTGS2 P35354 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18989846 0.91 NR1H2 (0.41) MEN1KMT2ANR1H2CYP1A2CYP2C19
SCHEMBL19014148 0.85 NR1H2 (0.39) MEN1KMT2ANR1H2CYP1A2CYP2C19
SCHEMBL18990513 0.82 NR1H2 (0.38) MEN1KMT2ANR1H2CYP1A2CYP2C19
SCHEMBL19013604 0.81 NR1H2 (0.39) KMT2ANR1H2CYP1A2CYP2C19AURKA
SCHEMBL29631879 0.81 NR1H2 (0.39) KMT2ANR1H2CYP1A2CYP2C19AURKA
SCHEMBL18984353 0.79 MDM2 (0.39) MEN1KMT2APOLBLMNANPSR1
SCHEMBL29631893 0.78 NR1H2 (0.40) NR1H2CYP1A2CYP2C19POLBCYP3A4
SCHEMBL29631921 0.78 CHRM2 (0.41) NR1H2L3MBTL1GABRG2GABRB3GABRA5
SCHEMBL2133036 0.78 CHRM2 (0.41) NR1H2L3MBTL1GABRG2GABRB3GABRA5
SCHEMBL19013553 0.78 NR1H2 (0.40) NR1H2CYP1A2CYP2C19POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106352-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-06-22 WO disclosed